𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chromosomal imbalances in small cell carcinomas of the urinary bladder

✍ Scribed by Terracciano, Luigi; Richter, Jan; Tornillo, Luigi; Beffa, Lorenza; Diener, Pierre-Andr�; Maurer, Robert; Gasser, Thomas C.; Moch, Holger; Mihatsch, Michael J.; Sauter, Guido

Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
245 KB
Volume
189
Category
Article
ISSN
0022-3417

No coin nor oath required. For personal study only.

✦ Synopsis

Small cell carcinomas (SCCs) represent a rare histological subtype of urinary bladder cancer. Little is known abut the genetic alterations in these tumours. To identify chromosomal aberrations that are typically present in SCC of the urinary bladder, ten tumours were analysed by comparative genomic hybridization (CGH). CGH allows screening for all relative DNA copy number gains and losses present in a tumour. SCCs of the bladder were characterized by a high number of genomic alterations (mean: 11•3 per tumour). Deletions were most frequent at 10q (7 of 10 tumours deleted), 4q, 5q (5/10 each), and 13q (4/10). These regions may carry tumour suppressor genes with relevance for this particular tumour type. Gains of DNA sequences were most prevalent at 8q (5/10), 5p, 6p, and 20q (4/10 each). High level amplifications were found at 1p22-32, 3q26.3, 8q24, and 12q14-21. These loci may pinpoint the localization of oncogenes with relevance for small cell bladder cancer. The analysis of one tumour having areas of both SCC and transitional cell carcinoma strongly suggests that SCC can develop from TCC through the acquisition of additional genetic alterations.

📜 SIMILAR VOLUMES

Small cell neuroendocrine carcinoma of t
Small cell neuroendocrine carcinoma of the urinary bladder : A clinicopathologic study with emphasis on cytologic features
✍ Syed Z. Ali; Victor E. Reuter; Maureen F. Zakowski 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 493 KB 👁 2 views

## Background: Primary small cell neuroendocrine carcinoma (scnec) of the urinary bladder is a rare but important entity. the authors have attempted to define the cytopathologic features of this tumor. ## Methods: Sixty-one urine specimens (16 with histologic correlation) from 23 patients were st

Survival of patients with carcinoma in s
Survival of patients with carcinoma in situ of the urinary bladder
✍ Liang Cheng; John C. Cheville; Roxann M. Neumann; Bradley C. Leibovich; Kathleen 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB 👁 2 views

## BACKGROUND. To the authors' knowledge, the long term follow-up of patients with carcinoma in situ of the urinary bladder is limited. ## METHODS. The authors studied 138 patients diagnosed with urothelial carcinoma in situ of the bladder at the Mayo Clinic between 1972-1979. All the histologi

Small cell carcinoma of the bladder : Lo
Small cell carcinoma of the bladder : Long term outcome with integrated chemoradiation
✍ Caroline Lohrisch; Nevin Murray; Tom Pickles; Lorne Sullivan 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

## BACKGROUND. Small cell carcinoma of the bladder (SCCB) is an uncommon tumor with approximately 8% 5-year survival reported in the literature for patients with disease confined to the pelvis. It exhibits biologic behavior similar to that of small cell carcinoma of the lung (SCLC). The authors so

Detailed marker chromosome analysis in c
Detailed marker chromosome analysis in cell line U-BLC1, established from transitional-cell carcinoma of the bladder
✍ Jochen Bruch; Gudrun Wöhr; Silke Brüderlein; Gotthold Barbi; Hubertus Wolter; Ch 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 301 KB 👁 1 views

A permanent cell line, U-BLC1, was established from a primary transitional-cell carcinoma, TCC, of the urinary bladder. Karyotype analysis showed the line to be highly aberrant, with a near-triploid chromosome number of 68 to 73. Comparative genomic hybridization revealed some distinct differences b